Article
Leptin-elicited PBX3 confers letrozole resistance in breast cancer
19 Feb 2021
Abstract excerpt
Aberrant leptin signaling and overexpression of fibroblast growth factor receptor 1 (FGFR1) are both implicated in the pathogenesis of letrozole resistance in breast cancer (BCa), but it remains unknown whether these two pathways are involved in letrozole resistance in a coordinated manner. Here, we demonstrate that expression levels of the pre-B-cell leukemia homeobox transcription factor 3 (PBX3), a pioneer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
